Slide

Boosting Immunity and Restoring Hope

Aulos Bioscience is dedicated to helping people live longer, healthier lives by unlocking IL-2 to fight cancer in ways never before possible.

A Fundamental Shift in Cancer Care

At Aulos, we’re on a journey to revolutionize cancer patient care through the development of pioneering IL-2 therapeutics that we believe will transform the treatment of solid tumor cancers. We’re taking on the toughest challenges that have limited the effectiveness of IL-2 therapies: the ability to shift IL-2 activity toward immune activation and away from immune suppression, and preventing the toxic side effects of interleukin-2, including vascular leak syndrome and pulmonary edema.

Aulos Bio AU-007

Latest News

Aulos stands apart through our new approach to long-standing obstacles in immunotherapy.

LEARN MORE →

AU-007: An Investigational Product Candidate

AU-007 achieves what we believe no other IL-2 therapeutic in development does: tip the balance toward immune activation and prevent binding to vasculature and pulmonary endothelium.

AU-007 Vial
Antibody icon

Our novel therapeutic candidate is designed to exquisitely direct the body’s immune system to kill tumor cells by more safely and effectively unleashing the anti-cancer power of IL-2.

LEARN MORE →